Suppr超能文献

肌肉减少症、肌肉减少性肥胖与炎症:1999 - 2004年美国国家健康与营养检查调查结果

Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.

作者信息

Batsis John A, Mackenzie Todd A, Jones Jonathan D, Lopez-Jimenez Francisco, Bartels Stephen J

机构信息

Section of General Internal Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH, United States; Geisel School of Medicine at Dartmouth and The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH, United States; Dartmouth Centers for Health and Aging, Dartmouth College, Hanover, NH, United States; Health Promotion Research Center at Dartmouth, Lebanon, NH, United States; Dartmouth Weight & Wellness Center, Lebanon, NH, United States.

Geisel School of Medicine at Dartmouth and The Dartmouth Institute for Health Policy & Clinical Practice, Lebanon, NH, United States.

出版信息

Clin Nutr. 2016 Dec;35(6):1472-1483. doi: 10.1016/j.clnu.2016.03.028. Epub 2016 Apr 7.

Abstract

BACKGROUND

The Foundation for the National Institutes of Health Sarcopenia Project validated cutpoints for appendicular lean mass (ALM) to identify individuals at risk for functional impairment. Recognizing possible underlying mechanisms between adipose tissue and muscle, we sought to apply the recent definitions and determine the relationship with markers of glucose homeostasis and inflammation in individuals with sarcopenia and sarcopenic obesity.

METHODS

The National Health and Nutrition Examination Surveys 1999-2004 were used to identify 4984 adults aged ≥60 years with DEXA measures. Sarcopenia was defined using ALM (men<19.75 kg, women<15.02 kg) and ALM adjusted for body mass index (BMI; men<0.789 kg/m, women<0.512 kg/m). Sarcopenic obesity was defined as subjects fulfilling the criteria for sarcopenia and obesity by body fat (men ≥25%, women ≥35%). We assessed the association between ALM and ALM:BMI with inflammatory and markers of glucose homeostasis, both as continuous variables but also classifying as having sarcopenic obesity or not after adjusting for confounding variables including pro-inflammatory chronic diseases such as diabetes and cancer.

RESULTS

Mean age was 71.1 years (56.5%) females. Prevalence of sarcopenia and sarcopenic obesity were (ALM definition: 29.9 and 24.4%; ALM:BMI definition: 23.0 and 22.7%). There were significant associations with ALM and ln C-reactive protein (β = 0.0287; p = 0.001), fibrinogen (β = 0.519; p < 0.001), and HOMA-IR (β = 0.359; p < 0.001). Using ALM:BMI, significant associations were observed with ln CRP (β = -2.58; p = 0.001), fibrinogen (β = -124.2; p < 0.001), and HOMA-IR (β = -6.63; p < 0.001). Sarcopenic obesity using the ALM:BMI definition demonstrated significant associations with CRP (β = 0.422; p < 0.001), fibrinogen (β = 22.5; p < 0.001), but not HOMA-IR (β = 1.19; p = 0.13). Strong associations with seen with increased levels of fibrinogen and CRP with sarcopenic obesity (ALM:BMI definition) that persisted after adjusting for diabetes and cancer.

CONCLUSIONS

Biologically plausible associations exist between ALM:BMI and inflammation and HOMA-IR that were not observed when using ALM alone. Future study should validate each of these definitions to prevent disparate results from being determined.

摘要

背景

美国国立卫生研究院肌肉减少症项目基金会验证了四肢瘦体重(ALM)的切点,以识别有功能障碍风险的个体。认识到脂肪组织与肌肉之间可能存在的潜在机制,我们试图应用最新定义,并确定肌肉减少症和肌肉减少性肥胖个体中其与葡萄糖稳态和炎症标志物的关系。

方法

利用1999 - 2004年国家健康与营养检查调查来识别4984名年龄≥60岁且进行了双能X线吸收法(DEXA)测量的成年人。肌肉减少症的定义采用ALM(男性<19.75千克,女性<15.02千克)以及根据体重指数(BMI)调整后的ALM(男性<0.789千克/米,女性<0.512千克/米)。肌肉减少性肥胖定义为符合肌肉减少症标准且体脂符合肥胖标准的受试者(男性≥25%,女性≥35%)。我们评估了ALM以及ALM:BMI与炎症和葡萄糖稳态标志物之间的关联,二者均作为连续变量,同时在调整包括糖尿病和癌症等促炎性慢性病等混杂变量后,将其分类为是否患有肌肉减少性肥胖。

结果

平均年龄为71.1岁,女性占56.5%。肌肉减少症和肌肉减少性肥胖的患病率分别为(ALM定义:29.9%和24.4%;ALM:BMI定义:23.0%和22.7%)。ALM与ln C反应蛋白(β = 0.0287;p = 0.001)、纤维蛋白原(β = 0.519;p < 0.001)以及胰岛素抵抗稳态模型评估(HOMA - IR,β = 0.359;p < 0.001)之间存在显著关联。使用ALM:BMI时,观察到与ln CRP(β = -2.58;p = 0.001)、纤维蛋白原(β = -124.2;p < 0.001)以及HOMA - IR(β = -6.63;p < 0.001)之间存在显著关联。采用ALM:BMI定义的肌肉减少性肥胖与CRP(β = 0.422;p < 0.001)、纤维蛋白原(β = 22.5;p < 0.001)存在显著关联,但与HOMA - IR无关(β = 1.19;p = 0.13)。在调整糖尿病和癌症因素后,纤维蛋白原和CRP水平升高与肌肉减少性肥胖(ALM:BMI定义)之间仍存在强关联。

结论

ALM:BMI与炎症和HOMA - IR之间存在生物学上合理的关联,而单独使用ALM时未观察到这种关联。未来的研究应验证这些定义中的每一个,以避免得出不同的结果。

相似文献

1
Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.
Clin Nutr. 2016 Dec;35(6):1472-1483. doi: 10.1016/j.clnu.2016.03.028. Epub 2016 Apr 7.
4
The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.
Obesity (Silver Spring). 2012 Oct;20(10):2101-6. doi: 10.1038/oby.2012.20. Epub 2012 Feb 7.

引用本文的文献

2
Hs-CRP/HDL-C ratio as a predictive inflammatory-lipid marker for sarcopenia: evidence from NHANES 2015-2018.
Front Immunol. 2025 Jun 19;16:1600421. doi: 10.3389/fimmu.2025.1600421. eCollection 2025.
3
Monitoring Sarcopenia With Incretin Receptor Activator Treatment.
J Diabetes. 2025 Jun;17(6):e70117. doi: 10.1111/1753-0407.70117.
4
Association of Serum Uric Acid With Relative Muscle Loss: A US Population-Based Cross-Sectional Study.
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13867. doi: 10.1002/jcsm.13867.
9
Association between residual cholesterol and sarcopenia in American adults.
Front Endocrinol (Lausanne). 2024 Nov 28;15:1461961. doi: 10.3389/fendo.2024.1461961. eCollection 2024.
10
Longitudinal analysis of insulin resistance and sarcopenic obesity in Chinese middle-aged and older adults: evidence from CHARLS.
Front Public Health. 2024 Nov 18;12:1472456. doi: 10.3389/fpubh.2024.1472456. eCollection 2024.

本文引用的文献

1
Diagnostic accuracy of body mass index to identify obesity in older adults: NHANES 1999-2004.
Int J Obes (Lond). 2016 May;40(5):761-7. doi: 10.1038/ijo.2015.243. Epub 2015 Dec 1.
5
The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.
J Gerontol A Biol Sci Med Sci. 2014 May;69(5):547-58. doi: 10.1093/gerona/glu010.
6
Prevalence of childhood and adult obesity in the United States, 2011-2012.
JAMA. 2014 Feb 26;311(8):806-14. doi: 10.1001/jama.2014.732.
8
The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.
Obesity (Silver Spring). 2012 Oct;20(10):2101-6. doi: 10.1038/oby.2012.20. Epub 2012 Feb 7.
9
Sarcopenia and mortality among older nursing home residents.
J Am Med Dir Assoc. 2012 Feb;13(2):121-6. doi: 10.1016/j.jamda.2011.07.004.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验